Table 2.
Test article | Chemical nature | Tested in | Source | Target microbe | Concentration tested | Vehicle | Model used | Effect | References |
---|---|---|---|---|---|---|---|---|---|
OH-CATH30 | Peptide | Rabbits | King Cobra | P. aeruginosa | 1 mg/mL | PBS | Abrasion | Reduced colony counts | 22 |
RC-2 | Theta defensin | Mouse | Nonhuman primate/synthetic | HSV-1 | 0.1% (wt/vol) | DMEM | Scarification | Reduced disease severity when used prophylactically | 27 |
Cecropin/Melitin | Hybrid peptide | Rabbit | Cecropia moth/bee | P. aeruginosa | 0.1% | PBS | Intrastromal injection | Modest reduction in disease severity | 30 |
Nona-d-arginine | Peptide | Mouse | Synthetic | P. aeruginosa | 10 and 100 μM | PBS | Scarification | Reduced colony counts | 38,39 |
CC1A, B, C, and Col-1 | Peptides | Rabbit | In silico designed synthetics | P. aeruginosa | 10 and 50 μg/mL | 0.5 methylcellulose±0.05% EDTA | Abrasion | Not effective | 20 |
G1 and G2 | Peptides | Mouse | Phage display synthetics | HSV-1 | 0.5 mM | PBS | Scarification | Reduced viral replication and less-severe disease | 32 |
Pc-C and Pc-E | Peptides | Mouse | Synthetic | A. fumigatis | 1 mg/mL | PBS | Scarification | Reduced growth, less-severe disease | 40 |
TAT-Cdo | Peptide | Mouse | HIV tat protein/synthetic | HSV-1 | 1% | PBS; tears naturale; 2% methylcellulose in PBS; Aquaphor based cream | Scarification | Reduced angiogenesis and stromal disease | 46 |
apoEdp | Peptide | Mouse/rabbit | Apolipoprotein E/synthetic | HSV-1 | 0.5 mM | PBS | Scarification | Very effective in reducing shedding and disease | 54–55 |
G2-ACV | Peptide-nucleoside analog conjugate | Ex vivo porcine cornea | Synthetic | HSV-1 | 10 μM | Normal saline | Scarification | Reduced viral antigen in tissue—not better than ACV alone | 68 |
ACV, Acyclovir; DMEM, Dulbecco's modified Eagle's medium; PBS, phosphate-buffered saline.